Effect of MetioNac ® in patients with metabolic syndrome who are at risk of metabolic dysfunction associated fatty liver disease: a randomized controlled trial

CONCLUSION: supplementation with MetioNac® may be protective against hyperlipidemia, insulin resistance, and overweight among metabolic syndrome patients. Further studies on this issue are needed in a larger population.PMID:37409712 | DOI:10.20960/nh.04635

Source: Nutricion Hospitalaria - July 6, 2023 Category: Nutrition Authors: Elena Garicano Vilar Sara Sanz Rojo Sara L ópez Oliva Silvia Mart ínez Ana Terr én Lora Ismael San Mauro Martin Source Type: research